Long-term effectiveness of zoledronic acid in patients with Paget ’s disease of bone – a retrospective cohort study

ConclusionThe majority of patients with PDB experience a mild disease course, marked by monostotic involvement and a low prevalence of fractures. Zoledronic acid effectively manages PDB, providing sustained biochemical response. The necessity for multiple zoledronic acid injections remains questionable, often implemented due to osteoporosis.

http://link.springer.com/10.1007/s12020-024-03791-7

Source: Endocrine - March 30, 2024 Category: Endocrinology Source Type: research